We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
We're a bit confused by FDA commish Martin Makary's statement that the agency is looking at restricting GLP-1 APIs for compounded drugs.
Drug companies continue to push for anti-compounding bills in state legislatures, and APC’s Compounding Defense Initiative continues to fight each ...
Don't wait any longer — the Owner Summit is almost full, and so it the hotel room block and the special rate that comes with it.
APC has a couple of white papers specifically written to squash drugmakers' misleading talking points.
Some of the latest news from the world of pharmacy compounding
.png?width=410&height=320&name=image-container%20(1).png)
.png?width=410&height=320&name=image-container%20(2).png)
.png?width=411&height=320&name=image-container%20(3).png)
.png?width=410&height=320&name=image-container%20(4).png)
.png)
.png?width=17&height=16&name=folder%20(1).png){kind=small}
%20Pharma-GS.png)
